APOB, apolipoprotein B, 338

N. diseases: 339; N. variants: 122
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 Biomarker disease BEFREE "Primary hypobetalipoproteinemia" refers to an eclectic group of inherited lipoprotein disorders characterized by low concentrations of or absence of low-density lipoprotein cholesterol and apolipoprotein B in plasma. 24781598 2014
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease CLINVAR Hypobetalipoproteinemia and abetalipoproteinemia. 24751931 2014
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families. 9508071 1998
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE We showed that heterozygotes for a new mutation in APOB have hypobetalipoproteinemia, despite a reduced binding of LDL to the LDL receptor. 15797858 2005
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. 2567736 1989
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 AlteredExpression disease LHGDN Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL. 15585207 2005
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 Biomarker disease BEFREE Apolipoprotein B-31 is the shortest of the mutant apo B species to be identified in the plasma of a subject with hypobetalipoproteinemia. 2312735 1990
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Diabetes mellitus in a new kindred with familial hypobetalipoproteinemia and an apolipoprotein B truncation (apoB-55). 9543100 1998
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 Biomarker disease BEFREE The control group showed a significantly higher apolipoprotein B (apoB) concentration compared with patients with chronic hepatitis C. Hypobetalipoproteinemia (apo B <0.7 g/L) was found in 27 (24.7%) chronic HCV patients and in five (5.3%) control subjects (p = 0.0002). 12809841 2003
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE The identification of ApoB loss-of-function mutations in type 1 diabetic patients presents innovative cases to study the interaction between hypobetalipoproteinemia and insulin deficiency. 25430706 2015
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5). 11019990 2000
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE These results demonstrated that in a cohort of subjects with severe primary hypobetalipoproteinemia the prevalence of ANGPTL3 gene mutations responsible for a combined hypolipidemia phenotype is about 10%, whereas mutations of APOB gene are absent. 22247256 2012
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia. 26323024 2015
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 AlteredExpression disease BEFREE When fed a diet rich in fat and cholesterol, heterozygous mice were protected from diet-induced hypercholesterolemia; these mice, which constitute an animal model for hypobetalipoproteinemia, should be useful for studying the effects of decreased apolipoprotein B expression on atherogenesis. 7878058 1995
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia. 12872264 2003
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. 19344897 2009
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 Biomarker disease BEFREE Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. 3473077 1987
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Here, we describe 2 children with severe hypobetalipoproteinemia found to be homozygous for novel APOB gene mutations. 26073401 2016
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene. 10807747 2000
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 AlteredExpression disease BEFREE Genetically modified mice have proven useful for investigating the genetic and environmental factors affecting atherogenesis, for defining apoB structure/function relationships, for understanding the regulation of the apoB gene expression in the intestine, for defining the "physiologic rationale" for the existence of the two different forms of apoB (apoB48 and apoB100) in mammalian metabolism and for providing mechanistic insights into the human apoB deficiency syndrome, familial hypobetalipoproteinemia. 10064308 1999
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia. 27179706 2016
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE Hypobetalipoproteinemia with an apparently recessive inheritance due to a "de novo" mutation of apolipoprotein B. 14732481 2004
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease BEFREE The molecular basis of truncated forms of apolipoprotein B in a kindred with compound heterozygous hypobetalipoproteinemia. 2614276 1989
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 CausalMutation disease CLINVAR
CUI: C0020597
Disease: Hypobetalipoproteinemias
Hypobetalipoproteinemias
0.200 GeneticVariation disease LHGDN Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia. 17158591 2007